Publications by authors named "Andrew Sharf"

Claim this Profile
E
Evaluation of mobilization efficacy with an extended interval following plerixafor administration.
Sarah E Stump, Morgan Trepte, J Ryan Shaw, Tatjana Grgic, Jonathan R Ptachcinski, Andrew Sharf

J Oncol Pharm Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation.
Jessica M Davis, Anastasia Ivanova, Yunro Chung, J Ryan Shaw, Kamakshi V Rao, Andrew A Sharf

Biol Blood Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased BCR responsiveness in B cells from patients with chronic GVHD.
Jessica L Allen, Prasanthi V Tata, Matthew S Fore, Jenna Wooten, Sharmistha Rudra, Andrew Sharf

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
Jessica L Allen, Matthew S Fore, Jenna Wooten, Philip A Roehrs, Nazmim S Bhuiya, Andrew Sharf

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development.
Yuri Fedoriw, T Danielle Samulski, Allison M Deal, Cherie H Dunphy, Andrew Sharf

Biol Blood Marrow Transplant· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant.
William Wood, Allison Deal, Julia Whitley, Andrew Sharf, Jonathan Serody

Pediatr Blood Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.
Anne W Beaven, Dominic T Moore, Andrew Sharf, Jonathan S Serody, Thomas C Shea

Cancer Invest· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy.
William A Wood, Julia Whitley, Dominic Moore, Andrew Sharf, Robert Irons

Biol Blood Marrow Transplant· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis